Evaluation of the Effectiveness of Obstetric Lubricant Gel in Labor in Nulliparous and Primiparous Women: A Randomized Controlled Study

Sponsor
Ankara University (Other)
Overall Status
Completed
CT.gov ID
NCT06069596
Collaborator
(none)
220
2
18.4

Study Details

Study Description

Brief Summary

The investigators hypothesized that the application of lubricant gels at the beginning of the active phase of the labor may reduce duration of the delivery and episiotomy rates. The aim of this study is to investigate and confirm this hypothesis through a randomised controlled trial.

All participants in the study received standard routine antepartum care in the delivery room. Obstetric lubricant gel was applied to patients in the study groups, which had 47 nulliparous and 50 primiparous patients. Perinatal outcomes were compared between the groups.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Natalis Obstetric Lubrican Gel
Phase 4

Detailed Description

The participants were divided into two groups based on their parity: nulliparous and primiparous. Initially, each group had 110 participants. Nulliparous and primiparous groups were randomly assigned to two groups as study and control groups using a computer-generated random number table. In this randomized controlled trial, participant allocation was carried out using a computer program to ensure a randomized and unbiased selection process. The randomization procedure was conducted in a double-blind manner, with the study investigators remaining unaware of the allocation until the conclusion of the study. All participants in the study received standard routine antepartum care in the delivery room. Among all patients, 25 participants were lost to follow-up during the study. Consequently, obstetric lubricant gel was applied to patients in the study groups, which included 47 nulliparous and 50 primiparous patients. Perinatal outcomes were compared between the groups

Study Design

Study Type:
Interventional
Actual Enrollment :
220 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The participants were divided into two groups based on their parity; nulliparous and primiparous. At the outset, each group had 110 participants. Nulliparous and primiparous groups were randomly assigned to two groups as study and control groups by using a computer generating random number table. Obstetric lubricant gel was applied to patients in the study groups. Perinatal outcomes and durations of the labor were compared between study and control groups.The participants were divided into two groups based on their parity; nulliparous and primiparous. At the outset, each group had 110 participants. Nulliparous and primiparous groups were randomly assigned to two groups as study and control groups by using a computer generating random number table. Obstetric lubricant gel was applied to patients in the study groups. Perinatal outcomes and durations of the labor were compared between study and control groups.
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Randomization was performed using a computer program. Accordingly, the study group patients were administered Obstetric gel. The researcher administering Obstetric gel ensured the blinding of healthcare providers and other researchers.
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Effectiveness of Obstetric Lubricant Gel in Labor in Nulliparous and Primiparous Women: A Randomized Controlled Study
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Apr 30, 2017
Actual Study Completion Date :
Jul 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Study group

obstetric lubricant gel was applied to patients in the study groups, which had 47 nulliparous and 50 primiparous patients.

Combination Product: Natalis Obstetric Lubrican Gel
The obstetric lubricant gel was applied to the vaginal canal with a special applicator at the beginning of the active phase of the labor. The gel used in the study was highly viscose and isotonic with a slight acid pH of 6.0 - 6.7 and contained hydroxyethylcellulose, propylene glycol, glycerin. The gel box contained a sterile syringe (15 ml) and a flexible applicator.

No Intervention: Control group

obstetric lubricant gel was not applied to patients in the control groups, which had 55 nulliparous and 43 primiparous patients.

Outcome Measures

Primary Outcome Measures

  1. The duration of the active phase of the first stage of labor was compared between the study and control groups [0 to 600 minutes]

    The active phase of labor begins when the cervical dilation is between 4-6 cm and refers to the time elapsed until full cervical dilation.

  2. The duration of the second stage of labor was compared between the study and control groups [0 to 240 minutes]

    The second stage of labor begins when the cervical dilation is complete and continues until the birth of the newborn.

Secondary Outcome Measures

  1. Episiotomy rates [Episiotomy is a technique performed during the second stage of labor.]

    differences between study and control groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Nulliparous and primiparous singleton pregnancies between 37 and 41 weeks + six days of gestation and vertex presentation of fetus with an estimated birth weight of 2000 - 4500g were included in the study
Exclusion Criteria:
  • Multiparous pregnancies and women who had ceserean section before and/or contraindication for vaginal delivery were excluded from the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ankara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
kaan baydemir, Investigator, Ankara University
ClinicalTrials.gov Identifier:
NCT06069596
Other Study ID Numbers:
  • 290819912
First Posted:
Oct 6, 2023
Last Update Posted:
Oct 12, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by kaan baydemir, Investigator, Ankara University

Study Results

No Results Posted as of Oct 12, 2023